More extensive surgery improves survival of patients with gastric cancer

March 26, 2006

Patients with gastric cancer have improved survival after more extensive removal of lymph nodes compared with those undergoing less extensive surgery, according to researchers from Taiwan reporting in the April issue of The Lancet Oncology.

In Taiwan, gastric cancer is the fifth most common cancer. Although surgery is the gold standard treatment for these patients, the role of radical lymph node dissection is still debated. Therefore, Prof Chew-Wun Wu (Taipai Veterans General Hospital, Taipei, Taiwan) and colleagues randomly assigned 221 patients to more extensive (D3) or less extensive (D1) surgery and compared 5-year overall survival in the two patient groups.

Patients in the D3 group had more short-term morbidity, more complications and blood loss, longer operation times, and longer hospital stays than those assigned to the D1 group. However, overall 5-year survival was significantly higher in D3 patients compared with those in the D1 group (59.5% vs. 53.6%).

Lead researcher Professor Wu states: "D3 nodal dissection, compared with that of D1, offers a survival benefit for patients with gastric cancer when done by well trained, experienced surgeons".

In an accompanying Reflection and Reaction article, Prof Mitchell Posner and Dr Kevin Roggin (University of Chicago Pritzker School of Medicine, Chicago, IL, USA) comment that "to our knowledge, this is the first study in which one group of experienced surgeons have assessed prospectively the absolute surgical effect of extended lymphadenectomy on survival with advanced gastric cancer". However, they add that: "A single institution trial with a unimodal surgical approach to advanced gastric cancer is not generalisable, and does not take into account the important contribution of adjuvant treatment".
-end-
Contact: Prof Chew-Wun Wu. Department of Surgery, Taipai Veterans General Hospital, ShiPai Road, Taipei, Taiwan, 11217 T) 886-2-28757536. cwwu@vghtpe.gov.tw

Contact: Dr Kevin K Roggin, University of Chicago Pritzker School of Medicine, Department of Surgery, 5841 S Maryland Avenue, MC5031, Chicago, IL 60637, USA. T) 1 773-834-4589 kroggin@surgery.bsd.uchicago.edu

Lancet

Related Gastric Cancer Articles from Brightsurf:

Immune protein IL-17A responsible for lethal side effects of gastric cancer
The formation of scar tissue, or fibrosis, as gastric cancer disseminates throughout the peritoneum can be more lethal than the cancer itself and can interfere with chemotherapy.

New method to help spot gastric cancer cells
Researchers from the Shenyang Institute of Automation (SIA) of the Chinese Academy of Science (CAS) and City University of Hong Kong (CityU), in cooperation with doctors from the First Hospital of China Medical University, jointly proposed an optically induced electrokinetics (OEK) microfluidic method for label-free separation and characterization of gastric cancer cells.

Taking aim at gastric cancer
A novel drug, named 'FerriIridium,' can simultaneously help diagnose and treat gastric cancer.

More interventions follow gastric bypass than gastric sleeve, large study shows
A study involving tens of thousands of bariatric surgery patients found that gastric bypass patients were significantly more likely than gastric sleeve patients to end up back in the hospital in the years following surgery.

Discoveries detail role of stem cell in deadly gastric cancer
A Cornell study provides important new insights into a common and deadly type of gastric cancer.

Comparing future risks associated with gastric bypass and gastric sleeve surgery
Research from the Harvard Pilgrim Health Care Institute finds that gastric bypass is associated with a higher risk of additional operations or other invasive procedures, compared to a gastric sleeve procedure.

Gastric cancer susceptibility marker discovered
Gastric cancer is often associated with a poor prognosis because it tends to be diagnosed at an advanced stage.

Eliminating common bacterial infection significantly decreases gastric cancer risk
Penn researchers are first to assess Helicobacter pylori infection and gastric cancer risk in Americans, certain demographics and ethnic groups.

New study explains how inflammation causes gastric cancer
Researchers from Kanazawa University and the Japan Agency for Medical Research and Development have solved the decades-old mystery of how stomach bacterium Helicobacter pylori causes gastric cancer.

Cardiff University researchers shed light on development of gastric cancer
Cardiff University researchers have uncovered new information about the underlying mechanisms for gastric cancer, providing hope of potential new therapies in the future.

Read More: Gastric Cancer News and Gastric Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.